Results 31 to 40 of about 17,499 (214)
Investigative and Clinical Urology, 2021 Purpose To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity ...
M. Shim, W. Bang, C. Oh, M. Kang, J. Cho
semanticscholar +1 more source
Medical archives, 2021 Background: One of the common pediatric issues is monosymptomatic nocturnal enuresis (MNE). MNE is involuntarily urine-voiding in night sleep without lower urinary tract symptoms, such as daytime frequency, incontinence, or urgency.
A. Purnomo, B. Daryanto, Pradana Nurhadi
semanticscholar +1 more source
Effects of desmopressin acetate administration in healthy dogs receiving prednisolone
Journal of Veterinary Internal Medicine, 2021 Background Glucocorticoids are used for a variety of purposes in veterinary medicine but often are associated with clinically important adverse effects. Polyuria and polydipsia are the most frustrating adverse effects noted by owners.
Pamela Galati +5 more
doaj +1 more source
Frontiers in Pediatrics, 2023 BackgroundThe desmopressin combined with anticholinergic agents for the treatment of nocturnal enuresis (NE) remains controversial. This meta-analysis assesses the efficacy and safety of desmopressin compared with desmopressin plus anticholinergic agents
Tong Cai, Yi Yao, Weigui Sun, Peipei Lei
doaj +1 more source
Deficiency of antidiuretic hormone: a rare cause of massive polyuria after kidney transplantation [PDF]
Korean Journal of Pediatrics, 2016 A 15-year-old boy, who was diagnosed with Alport syndrome and end-stage renal disease, received a renal transplant from a living-related donor. On postoperative day 1, his daily urine output was 10,000 mL despite normal graft function.
Kyung Mi Jang +4 more
doaj +1 more source
Ожирение и метаболизм, 2014 Objective: To evaluate the effectiveness and conduct a comparative analysis of consumer qualities of desmopressin intranasal drops 0.01% 5ml ("Biopharm", Georgia) in patients with central diabetes insipidus (CDI).
doaj +1 more source
Scientific Reports, 2020 Von Willebrand factor (VWF) plays a major role in arterial thrombosis. Antiplatelet drugs induce only a moderate relative risk reduction after atherothrombosis, and their inhibitory effects are compromised under high shear rates when VWF levels are ...
Katarina D Kovacevic +8 more
semanticscholar +1 more source
Continence, 2023 Aim:: To conduct a systematic review and meta-analysis of all randomized placebo-controlled trials (RCTs) that evaluated the efficacy and safety of desmopressin versus placebo among females with nocturia. Methods:: PubMed, Scopus, Web of Science, CENTRAL,
Jawaher A. Alsahabi +5 more
doaj +1 more source
Short Term Effect and Safety of Antidiuretic Hormone in the Patients with Nocturia [PDF]
International Neurourology Journal, 2010 Purpose To investigate the short-term safety of antidiuretic hormone in elderly patients with nocturnal polyuria, focus on hyponatremia and others electrolytes disturbances and to assess short-term effects on nocturnal urine output and number of ...
Dong Il Kang +5 more
doaj +1 more source
Case Reports in Ophthalmology, 2018 Purpose: To describe the possible association between central serous chorioretinopathy (CSCR) and desmopressin use. Methods: The case histories of 2 middle-aged men with CSCR using desmopressin nasal spray were studied. Results: The diagnosis of CSCR was
Nacima Kisma +2 more
doaj +1 more source